Thu, March 19, 2020

Raghuram Selvaraju Upgraded (SWTX) to Strong Buy and Increased Target to $60 on, Mar 19th, 2020

Raghuram Selvaraju of HC Wainwright & Co., Upgraded "SpringWorks Therapeutics, Inc." (SWTX) to Strong Buy and Increased Target from $40 to $60 on, Mar 19th, 2020.

Raghuram has made no other calls on SWTX in the last 4 months.



There is 1 other peer that has a rating on SWTX. Out of the 1 peers that are also analyzing SWTX, all agrees with Raghuram's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Robert Burns of "HC Wainwright & Co." Downgraded from Strong Buy to Hold and Held Target at $40 on, Wednesday, March 4th, 2020